Insider trades
Douglas F. Kling, COO of NewAmsterdam Pharma NAMS, has filed 0 purchases and 19 sales on the open market. The latest trade was on 25/07/16.
Douglas F. Kling
COO
- Company
- NewAmsterdam Pharma NAMS
- First filing
- 24/01/03
- Trades
- 53 trades
- Buys / sales
- 0 / 19
- 12-month net buying
- No record
- Last trade
- 25/07/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NAMS | Open-market sale10b5-1 plan | 25/07/15–25/07/16 | 25/07/17 | 98,612 sh3 trades | $21.26avg. | $2,096,655.08 | −69.1% |
NAMS | Open-market sale10b5-1 plan | 25/06/16 | 25/06/18 | 100,000 sh2 trades | $19.29avg. | $1,929,141.04 | −69.4% |
| Open-market sale10b5-1 plan | 25/05/15 | 25/05/19 | 100,000 sh | In footnote | No stated value | −69.4% | |
NAMS | Open-market sale10b5-1 plan | 25/04/15 | 25/04/17 | 100,000 sh2 trades | No stated value | No stated value | −69.4% |
| Open-market sale | 25/03/26 | 25/03/28 | 16,539 sh | In footnote | No stated value | −27.3% | |
| Open-market sale10b5-1 plan | 25/03/17 | 25/03/19 | 100,000 sh | In footnote | No stated value | −69.4% | |
NAMS | Open-market sale10b5-1 plan | 25/02/18–25/02/19 | 25/02/20 | 100,000 sh2 trades | No stated value | No stated value | −69.4% |
NAMS | Open-market sale10b5-1 plan | 25/01/29–25/01/30 | 25/01/31 | 70,441 sh3 trades | No stated value | No stated value | −61.6% |
NAMS | Open-market sale10b5-1 plan | 25/01/27–25/01/28 | 25/01/29 | 129,559 sh4 trades | No stated value | No stated value | −74.6% |